Sanofi | 6-K: Colletion of Recent Announcements
Sanofi | 6-K: Sanofi Q1 Robust 7% Sales Growth Driven by Launches, Underpins Full-Year Guidance
Sanofi | 20-F: Registration statement / Annual report / Transition report
Sanofi | 6-K: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi: FY2022 Annual Report
20-F | Sanofi (0001121404) (Filer)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)
No Data